Pediatric Environmental Health Overview

Principles

Definition

Pediatric environmental health is the academic and research field dedicated to investigating the interactions between environmental exposures and the health outcomes of infants, children, and adolescents. This multidisciplinary area examines how physical, chemical, biological, and social environmental agents influence child development, disease susceptibility, and long-term health trajectories, aiming to identify risks and inform preventive strategies for optimal pediatric well-being.

Ontological type

Health Outcomes

Core Exposures

Prevention Strategies

Key developments

Key Figures

Exposure-Driven Prevention era

Joel Schwartz [1], affiliated with Harvard University [3] and Johns Hopkins University [4], was a leading figure in pediatric environmental health during the Exposure-Driven Prevention era (1985-2004). The Contribution of Lead-Contaminated House Dust and Residential Soil to Children's Blood Lead Levels [8] and Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities [7] were among Schwartz's key papers highlighting exposure pathways and economic burdens informing primary prevention. Michael Weitzman [2], affiliated with University of Massachusetts Chan Medical School [5] and Boston University [6], contributed to pediatric environmental health during this era. Prenatal and Postnatal Environmental Tobacco Smoke Exposure and Children’s Health [9] advanced understanding of how tobacco smoke exposure affects child health and informed prevention and policy efforts in environmental health.

Low-Level Lead Neurotoxicity era

Kimberly Yolton [1] is a leading figure in pediatric environmental health associated with the University of North Carolina at Chapel Hill [3] and the University of Cincinnati [4] during the Low-Level Lead Neurotoxicity era. Her key contributions include Low-Level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis [7], Principles and Practices of Neurodevelopmental Assessment in Children: Lessons Learned from the Centers for Children’s Environmental Health and Disease Prevention Research [8], and Methodologic and Logistic Issues in Conducting Longitudinal Birth Cohort Studies: Lessons Learned from the Centers for Children’s Environmental Health and Disease Prevention Research [9], which helped redefine dose–response at very low lead levels and strengthen standardized neurodevelopmental assessment and longitudinal cohort approaches in this era. Bruce P. Lanphear [2] is associated with Harvard University [5] and Johns Hopkins University [6] during this period. His key contributions include Low-Level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis [7], Screening Housing to Prevent Lead Toxicity in Children [10], and Methodologic and Logistic Issues in Conducting Longitudinal Birth Cohort Studies: Lessons Learned from the Centers for Children’s Environmental Health and Disease Prevention Research [9], which together informed dose–response understanding, housing-focused prevention, and the design of robust longitudinal cohorts in this era.

Pediatric Exposome Integration era

John D. Meeker [1] is a leading figure in pediatric environmental health during this era, with affiliations to Harvard University [3] and the University of Michigan [4]. His key contribution in this era centers on synthesizing exposure to environmental endocrine disruptors and child development, as highlighted in the 2012 paper Exposure to Environmental Endocrine Disruptors and Child Development [7], which helped establish early-life chemical burdens as central to pediatric risk assessment. Robert L. Jones [2] is a prominent figure connected with the Chinese University of Hong Kong [5] and the University of Strathclyde [6] during this period. His contributions include the Update of the Blood Lead Reference Value — United States, 2021 [8], a policy-centered benchmark update, and the Measurement Challenges at Low Blood Lead Levels [9], which clarified detection limits and improved low-level exposure assessment.